CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-01 | BAY CITY CAPITAL LLC 10% owner | Other disposition | −43,537 | 2,310,521 | ||
| 2020-09-04 | BAY CITY CAPITAL LLC 10% owner | Other disposition | −1,468,350 | 2,260,791 | ||
| 2020-09-04 | BAY CITY CAPITAL LLC 10% owner | Other disposition | −31,650 | 49,730 | ||
| 2020-09-04 | BAY CITY CAPITAL LLC 10% owner | Other disposition | −45,460 | 43,537 | ||
| 2020-09-04 | CRAVES FRED B Director | Other disposition | −1,468,350 | 2,260,791 | ||
| 2020-09-04 | CRAVES FRED B Director | Other disposition | −31,650 | 49,730 | ||
| 2020-09-04 | CRAVES FRED B Director | Other disposition | −45,460 | 43,537 | ||
| 2020-08-19 | BAY CITY CAPITAL LLC 10% owner | Sale | −7,303 | $107.64 | $786K | 42,875 |
| 2020-08-19 | CRAVES FRED B Director | Sale | −7,303 | $107.64 | $786K | 42,875 |
| 2020-08-18 | BAY CITY CAPITAL LLC 10% owner | Sale | −10,197 | $110.03 | $1.1M | 50,178 |
| 2020-08-18 | CRAVES FRED B Director | Sale | −10,197 | $110.03 | $1.1M | 50,178 |
| 2020-08-17 | BAY CITY CAPITAL LLC 10% owner | Sale | −12,500 | $110.73 | $1.4M | 60,375 |
| 2020-08-17 | CRAVES FRED B Director | Sale | −12,500 | $110.73 | $1.4M | 60,375 |
| 2020-08-06 | Lynch Brian Joseph See Remarks | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-06-17 | Daly James M Director | Grant or award · Stock Option (Right to Buy) | +6,000 | 6,000 | ||
| 2020-06-17 | Gollust Keith R Director | Grant or award · Stock Option (Right to Buy) | +6,000 | 6,000 | ||
| 2020-06-17 | BATE KENNETH Director | Grant or award · Stock Option (Right to Buy) | +6,000 | 6,000 | ||
| 2020-06-17 | MILLIGAN DAVID V Director | Grant or award · Stock Option (Right to buy) | +6,000 | 6,000 | ||
| 2020-06-17 | Levy Richard S Director | Grant or award · Stock Option (Right to buy) | +6,000 | 6,000 | ||
| 2020-06-17 | CRAVES FRED B Director | Grant or award · Stock Option (Right to Buy) | +6,000 | 6,000 |
Page 53 of 82 · 1,629 trades